Basic Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. May 15, 2025; 17(5): 105604
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.105604
Figure 1
Figure 1 Expression of P504S and IMP3 in lesions of atypical hyperplasia, low-grade dysplasia, high-grade dysplasia, and adenocarcinoma. A-D: Expression of P504S in atypical hyperplasia (AH), low-grade dysplasia (LGD), high-grade dysplasia (HGD), and adenocarcinoma (AC); E-H: Expression of IMP3 in AH, LGD, HGD, and AC. (IHC × 100).